Related Experiment Video
Updated: May 24, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
Differential regulation of osteoclastogenesis by Notch2/Delta-like 1 and Notch1/Jagged1 axes
Chiyoko Sekine1, Akemi Koyanagi, Noriko Koyama
1Department of Immunology, Juntendo University School of Medicine, 2-1-1 Hongo, Tokyo, 113-8421, Japan. csekine@juntendo.ac.jp
Introduction:
Osteoclastogenesis plays an important role in the bone erosion of rheumatoid arthritis (RA). Recently, Notch receptors have been implicated in the development of osteoclasts. However, the responsible Notch ligands have not been identified yet. This study was undertaken to determine the role of individual Notch receptors and ligands in osteoclastogenesis.
Methods:
Mouse bone marrow-derived macrophages or human peripheral blood monocytes were used as osteoclast precursors and cultured with receptor activator of nuclear factor-kappaB ligand (RANKL) and macrophage-colony stimulating factor (M-CSF) to induce osteoclasts. Osteoclasts were detected by tartrate-resistant acid phosphatase (TRAP) staining. K/BxN serum-induced arthritic mice and ovariectomized mice were treated with anti-mouse Delta-like 1 (Dll1) blocking monoclonal antibody (mAb).
Results:
Blockade of a Notch ligand Dll1 with mAb inhibited osteoclastogenesis and, conversely, immobilized Dll1-Fc fusion protein enhanced it in both mice and humans. In contrast, blockade of a Notch ligand Jagged1 enhanced osteoclastogenesis and immobilized Jagged1-Fc suppressed it. Enhancement of osteoclastogenesis by agonistic anti-Notch2 mAb suggested that Dll1 promoted osteoclastogenesis via Notch2, while suppression by agonistic anti-Notch1 mAb suggested that Jagged1 suppressed osteoclastogenesis via Notch1. Inhibition of Notch signaling by a gamma-secretase inhibitor suppressed osteoclastogenesis, implying that Notch2/Dll1-mediated enhancement was dominant. Actually, blockade of Dll1 ameliorated arthritis induced by K/BxN serum transfer, reduced the number of osteoclasts in the affected joints and suppressed ovariectomy-induced bone loss.
Conclusions:
The differential regulation of osteoclastogenesis by Notch2/Dll1 and Notch1/Jagged1 axes may be a novel target for amelioration of bone erosion in RA patients.
Insights
Blocking Delta-like 1 (Dll1) inhibits osteoclastogenesis, while Jagged1 enhances it, offering new therapeutic targets for rheumatoid arthritis (RA) bone erosion.
Area of Science:
- Immunology
- Cell Biology
- Rheumatology
Background:
- Osteoclastogenesis is crucial in rheumatoid arthritis (RA) bone erosion.
- Notch receptors are involved in osteoclast development.
- Specific Notch ligands driving this process in RA remained unidentified.
Purpose of the Study:
- To identify the specific Notch receptors and ligands involved in osteoclastogenesis.
- To elucidate the distinct roles of Notch ligands in regulating osteoclast formation.
- To explore potential therapeutic targets for RA-related bone erosion.
Main Methods:
- Osteoclast precursors (mouse macrophages/human monocytes) were cultured with RANKL and M-CSF.
- Osteoclast differentiation was assessed via TRAP staining.
- In vivo studies utilized K/BxN serum-induced arthritis and ovariectomized mouse models treated with blocking antibodies or fusion proteins targeting Notch ligands (Dll1, Jagged1).
Main Results:
- Blocking Delta-like 1 (Dll1) inhibited osteoclastogenesis, while Dll1-Fc enhanced it.
- Blocking Jagged1 enhanced osteoclastogenesis, while Jagged1-Fc suppressed it.
- Dll1 promoted osteoclastogenesis via Notch2, and Jagged1 suppressed it via Notch1. Dll1/Notch2 pathway dominance was observed. Dll1 blockade ameliorated arthritis and reduced bone loss in vivo.
Conclusions:
- The Notch2/Dll1 and Notch1/Jagged1 signaling pathways differentially regulate osteoclastogenesis.
- Targeting these specific Notch axes presents a novel therapeutic strategy for mitigating bone erosion in rheumatoid arthritis.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Osteoclasts in Bone Remodeling
Regulation of Angiogenesis and Blood Supply
Non-Canonical Wnt Signaling Pathways
